A Study of Measurable Ultrasound Imaging Biomarkers of Crohn's Disease

Overview

About this study

The purpose of this study is to assess the effectiveness of a new multi-parameter ultrasound technology for evaluation of Crohn’s disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Aims 1 and 2:

  • Patients with clinically indicated contrast enhanced MRI/CT for evaluation of Crohn’s disease.
  • Patients with involvement of terminal ileum.
  • Patients aged greater than 18 years old.

Aim 3:

  • CD patients scheduled to have surgical resection of terminal ileum.
  • CD patients age above 18 years old.

Exclusion Criteria:

  • Vulnerable subjects such as prisoners and adults lacking capacity to consent.

 

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Open for enrollment

Contact information:

Jill Weston

(507) 538-4981

Weston.Jill@mayo.edu

More information

Publications

Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available